Found: 99
Select item for more details and to access through your institution.
Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib.
- Published in:
- 2016
- By:
- Publication type:
- journal article
UGT2B7 promoter variant −840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 3, p. 200, doi. 10.1002/ajh.21051
- By:
- Publication type:
- Article
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00239
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Controlled-Release Disopyramide in Patients with Cardiac Arrhythmias.
- Published in:
- 1988
- By:
- Publication type:
- Other
Clinical and Electrophysiologic Effects of Flecainide in Patients with Refractory Ventricular Tachycardia.
- Published in:
- 1988
- By:
- Publication type:
- Other
Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 2, p. 272, doi. 10.1093/cid/ciad199
- By:
- Publication type:
- Article
Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S562, doi. 10.1093/cid/ciac754
- By:
- Publication type:
- Article
Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 6, p. 1037, doi. 10.1093/cid/ciac001
- By:
- Publication type:
- Article
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 3, p. 388, doi. 10.1093/cid/ciaa028
- By:
- Publication type:
- Article
Meeting Practical Challenges of a Trial Involving a Multitude of Treatment Regimens: An Example of a Multi-Center Randomized Controlled Clinical Trial in NeuroAIDS.
- Published in:
- Journal of NeuroImmune Pharmacology, 2007, v. 2, n. 2, p. 97, doi. 10.1007/s11481-006-9057-8
- By:
- Publication type:
- Article
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 1, p. 24, doi. 10.1067/mcp.2001.115891
- By:
- Publication type:
- Article
Pharmacokinetics of zidovudine in infants: A population analysis across studies<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 66, n. 1, p. 16, doi. 10.1016/S0009-9236(99)70049-4
- By:
- Publication type:
- Article
Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 12, p. 1862, doi. 10.1093/cid/civ688
- By:
- Publication type:
- Article
Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 10, p. 1582, doi. 10.1093/cid/civ587
- By:
- Publication type:
- Article
Current Research Issues in the Pharmacokinetics of Antiretroviral Drugs in Children.
- Published in:
- Current Pediatric Reviews, 2011, v. 7, n. 3, p. 166, doi. 10.2174/157339611796548357
- By:
- Publication type:
- Article
Pharmacokinetics of single-dose ceftaroline fosamil in children with cystic fibrosis.
- Published in:
- Pediatric Pulmonology, 2017, v. 52, n. 11, p. 1424, doi. 10.1002/ppul.23827
- By:
- Publication type:
- Article
Low-dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial.
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 7, p. 491, doi. 10.1002/acn3.424
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure.
- Published in:
- Clinical Pharmacology & Therapeutics, 1988, v. 43, n. 5, p. 536, doi. 10.1038/clpt.1988.69
- By:
- Publication type:
- Article
S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1349, doi. 10.1007/s00228-021-03123-y
- By:
- Publication type:
- Article
Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 4, p. 407, doi. 10.1007/s00228-011-1136-y
- By:
- Publication type:
- Article
Pediatric AIDS-Therapeutic Successes Built on a Foundation of Pediatric Clinical Pharmacology with Pharmacokinetic-Pharmacodynamic Modeling.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2022, v. 27, n. 6, p. 482, doi. 10.5863/1551-6776-27.6.482
- By:
- Publication type:
- Article
Use of Simulation Strategies to Predict Subtherapeutic Meropenem Exposure Caused by Augmented Renal Clearance in Critically Ill Pediatric Patients With Sepsis.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2020, v. 25, n. 5, p. 413, doi. 10.5863/1551-6776-25.5.413
- By:
- Publication type:
- Article
Neoral pharmacokinetics in Latino and Caucasian pediatric renal transplant recipients.
- Published in:
- Pediatric Nephrology, 2001, v. 16, n. 4, p. 311, doi. 10.1007/s004670000558
- By:
- Publication type:
- Article
Auranofin Is Highly Efficacious against Toxoplasma gondii In Vitro and in an In Vivo Experimental Model of Acute Toxoplasmosis.
- Published in:
- PLoS Neglected Tropical Diseases, 2014, v. 8, n. 7, p. 1, doi. 10.1371/journal.pntd.0002973
- By:
- Publication type:
- Article
Auranofin Is Highly Efficacious against <i>Toxoplasma gondii In Vitro</i> and in an <i>In Vivo</i> Experimental Model of Acute Toxoplasmosis.
- Published in:
- PLoS Neglected Tropical Diseases, 2014, v. 8, n. 7, p. 1, doi. 10.1371/journal.pntd.0002973
- By:
- Publication type:
- Article
A clinical trial of enteral Levetiracetam for acute seizures in pediatric cerebral malaria.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 7, p. 638, doi. 10.1002/phar.2703
- By:
- Publication type:
- Article
Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 4, p. 405, doi. 10.1002/phar.2512
- By:
- Publication type:
- Article
Etravirine in CSF is highly protein bound.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Etravirine in CSF is highly protein bound.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 5, p. 1161
- By:
- Publication type:
- Article
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 3, p. 684
- By:
- Publication type:
- Article
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 2, p. 354, doi. 10.1093/jac/dkq434
- By:
- Publication type:
- Article
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 6, p. 1265, doi. 10.1093/jac/dkp351
- By:
- Publication type:
- Article
Meropenem pharmacokinetics during relapsing peritonitis due to ESBL‐producing Enterobacteriaciae in a liver transplant recipient.
- Published in:
- Clinical Case Reports, 2019, v. 7, n. 11, p. 2169, doi. 10.1002/ccr3.2398
- By:
- Publication type:
- Article
Intraperitoneal vancomycin for peritoneal dialysis-associated peritonitis in children: Evaluation of loading dose guidelines.
- Published in:
- Peritoneal Dialysis International, 2021, v. 41, n. 2, p. 202, doi. 10.1177/0896860820950924
- By:
- Publication type:
- Article
Cannabidiol Exposure Through Maternal Marijuana Use: Predictions in Breastfed Infants.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 11, p. 1611, doi. 10.1007/s40262-023-01307-6
- By:
- Publication type:
- Article
Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1105, doi. 10.1007/s40262-023-01265-z
- By:
- Publication type:
- Article
Concurrent Use of Efavirenz and Oxcarbazepine May Not Affect Efavirenz Plasma Concentrations.
- Published in:
- Clinical Infectious Diseases, 2006, v. 43, n. 1, p. 116
- By:
- Publication type:
- Article
Evaluation of Pharmacokinetics, Safety, Tolerance, and Activity of Combination of Zalcitabine and Zidovudine in Stable, Zidovudine-Treated Pediatric Patients with Human Immunodeficiency Virus Infection.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 5, p. 1039
- By:
- Publication type:
- Article
Intravitreous and Plasma Concentrations of Ganciclovir and Foscarnet after Intravenous Therapy in Patients with AIDS and Cytomegalovirus Retinitis.
- Published in:
- Journal of Infectious Diseases, 1995, v. 172, n. 4, p. 951
- By:
- Publication type:
- Article
Intravitreal Ganciclovir Concentration after Intravenous Administration in AIDS Patients with Cytomegalovirus Retinitis: Implications for Therapy.
- Published in:
- Journal of Infectious Diseases, 1993, v. 168, n. 6, p. 1506, doi. 10.1093/infdis/168.6.1506
- By:
- Publication type:
- Article
Dosing of 3 Targeted Agents in Novel Drug Combinations Used at the Precision Medicine Clinic of the University of California San Diego.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2023, v. 13, n. 1, p. 19
- By:
- Publication type:
- Article
Translating Clinical Pharmacology Data in Pregnancy to Evidence‐Based Guideline Recommendations: Perspectives From the HIV Field.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, p. S188, doi. 10.1002/jcph.2240
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 2, p. 240, doi. 10.1002/jcph.1515
- By:
- Publication type:
- Article
Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy Adults.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 11, p. 1495, doi. 10.1002/jcph.1440
- By:
- Publication type:
- Article